[go: up one dir, main page]

MXPA03006001A - Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos. - Google Patents

Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos.

Info

Publication number
MXPA03006001A
MXPA03006001A MXPA03006001A MXPA03006001A MXPA03006001A MX PA03006001 A MXPA03006001 A MX PA03006001A MX PA03006001 A MXPA03006001 A MX PA03006001A MX PA03006001 A MXPA03006001 A MX PA03006001A MX PA03006001 A MXPA03006001 A MX PA03006001A
Authority
MX
Mexico
Prior art keywords
salts
preparation
same
acyclic nucleoside
phosphonate derivatives
Prior art date
Application number
MXPA03006001A
Other languages
English (en)
Inventor
Choi Jong-Ryoo
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of MXPA03006001A publication Critical patent/MXPA03006001A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03006001A 2001-01-19 2002-01-18 Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos. MXPA03006001A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010003087 2001-01-19
PCT/KR2002/000086 WO2002057288A1 (en) 2001-01-19 2002-01-18 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same

Publications (1)

Publication Number Publication Date
MXPA03006001A true MXPA03006001A (es) 2003-09-10

Family

ID=36241797

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006001A MXPA03006001A (es) 2001-01-19 2002-01-18 Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos.

Country Status (22)

Country Link
US (3) US7157448B2 (es)
EP (1) EP1358198B1 (es)
JP (1) JP3959348B2 (es)
KR (1) KR100441638B1 (es)
CN (1) CN100347185C (es)
AR (1) AR035933A1 (es)
AT (1) ATE478887T1 (es)
AU (1) AU2002230230B2 (es)
BR (1) BR0206165A (es)
CA (1) CA2433591C (es)
DE (1) DE60237429D1 (es)
DK (1) DK1358198T3 (es)
EG (1) EG24382A (es)
ES (1) ES2350197T3 (es)
MX (1) MXPA03006001A (es)
MY (1) MY141789A (es)
NZ (1) NZ526632A (es)
PL (1) PL212730B1 (es)
PT (1) PT1358198E (es)
RU (1) RU2266294C2 (es)
WO (1) WO2002057288A1 (es)
ZA (1) ZA200304181B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141789A (en) 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
US20060079493A1 (en) * 2001-03-01 2006-04-13 Lawrence Fritz Methods for treating genetically- defined proliferative disorders with hsp90 inhibitors
JP4397691B2 (ja) 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Ｈｓｐ９０阻害活性を有するプリン類似体
RU2005108601A (ru) * 2002-09-26 2006-01-20 Эл Джи Лайф Сайенсиз Лтд. (Kr) (+)-транс-изомеры(1-фосфонометокси-2-алкилциклопропил)метилнуклеозидные производные, способ получения их стереоизомеров и применение указанных соединений в качестве противовирусных средств
KR20060070572A (ko) 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Ｈｓｐ90-저해제로서의 신규 헤테로시클릭 화합물
KR20050062940A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-할로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
KR20050062944A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-클로로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
WO2005079812A1 (en) * 2004-02-17 2005-09-01 Lg Life Sciences Ltd. Nucleoside phosphonate derivatives useful in the treatment of hiv infections
KR101033290B1 (ko) * 2004-07-02 2011-05-09 주식회사 엘지생명과학 다이아이소프로필((1-(하이드록시메틸)-사이클로프로필)옥시)메틸포스포네이트의 새로운 제조 방법
US8101745B2 (en) 2004-12-16 2012-01-24 The Regents Of The University Of California Lung-targeted drugs
EP1869027A4 (en) 2005-03-30 2010-06-23 Conforma Therapeutics Corp ALKYNYL-PYRROLOPYRIMIDINES AND CORRESPONDING ANALOGS AS HSP90 INHIBITORS
US8434912B2 (en) * 2006-02-27 2013-05-07 Illumination Management Solutions, Inc. LED device for wide beam generation
EP2942611B1 (en) * 2006-02-27 2022-04-06 Signify Holding B.V. An apparatus for use in a street light installation
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
CL2008000070A1 (es) * 2007-01-17 2008-07-25 Lg Life Sciences Ltd Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
NZ608343A (en) 2007-04-13 2014-09-26 Southern Res Inst Anti-angiogenic agents and methods of use
AU2008254676B2 (en) * 2007-05-21 2012-03-22 Illumination Management Solutions, Inc. An improved LED device for wide beam generation and method of making the same
MX2011001685A (es) * 2008-08-14 2011-08-17 Cooper Technologies Co Dispositivos de led para la generacion de dispersion amplia de haz.
US8256919B2 (en) * 2008-12-03 2012-09-04 Illumination Management Solutions, Inc. LED replacement lamp and a method of replacing preexisting luminaires with LED lighting assemblies
CN102093422B (zh) * 2009-12-10 2015-02-25 中国人民解放军军事医学科学院毒物药物研究所 无环核苷膦酸酯衍生物及其医药用途
CN102286026B (zh) * 2010-06-18 2014-07-02 中国人民解放军军事医学科学院毒物药物研究所 无环核苷酸类似物的盐及其晶型和药物组合物
CN103338754A (zh) 2010-12-10 2013-10-02 西格玛制药实验有限责任公司 口服活性核苷酸类似物或口服活性核苷酸类似物前药的高度稳定组合物
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
CN105246902B (zh) 2013-03-15 2018-05-04 加利福尼亚大学董事会 无环核苷膦酸二酯
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
CN111808136B (zh) 2014-09-15 2024-06-11 加利福尼亚大学董事会 核苷酸类似物
CN106432330B (zh) * 2015-08-11 2019-02-01 天津科伦药物研究有限公司 Lb80380药物的中间体化合物及其制备方法和用途
EP3875462A1 (en) 2015-09-15 2021-09-08 The Regents of The University of California Nucleotide analogs
CN106977548A (zh) * 2016-01-19 2017-07-25 四川海思科制药有限公司 倍司福韦复合物及其制备方法和用途
CN107849074A (zh) * 2016-01-19 2018-03-27 四川海思科制药有限公司 一种核苷类似物的烷氧烷基酯前药及其应用
KR102623581B1 (ko) 2016-07-18 2024-01-11 일동제약(주) 항바이러스성 약물의 오로트산염, 이의 제조 방법 및 상기 염을 포함하는 약제학적 조성물
CN108276443A (zh) * 2017-01-06 2018-07-13 米文君 一种新的化合物及其用途
KR102096144B1 (ko) * 2017-07-03 2020-04-01 주식회사 엘지화학 포스포네이트 뉴클레오사이드계 b형 간염 치료제 합성용 중간체 화합물의 연속식 제조방법
CN108997429B (zh) * 2018-07-27 2020-10-30 广州粤美医药科技有限公司 一种制备贝西福韦的方法
CN113735863A (zh) * 2021-09-29 2021-12-03 武汉九州钰民医药科技有限公司 Wee1抑制剂adavosertib的制备工艺
CN113880883A (zh) * 2021-11-11 2022-01-04 奥锐特药业股份有限公司 核苷类磷酸酯前药的制备方法
CN114560463B (zh) * 2022-03-23 2023-10-20 福州大学 一种核壳结构的氮掺杂碳壳包裹碳化钼核微米球材料的制备方法
AU2023310177A1 (en) 2022-07-21 2025-03-06 Antiva Biosciences, Inc. Compositions and dosage forms for treatment of hpv infection and hpv-induced neoplasia

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1494321A (en) * 1974-08-08 1977-12-07 Ici Ltd Prostanoic acid derivatives
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
US5177104A (en) 1990-04-03 1993-01-05 E. R. Squibb & Sons, Inc. 6-α-hydroxy derivatives of mevinic acids
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
DE69116750T2 (de) * 1990-07-04 1996-11-14 Merrell Dow Pharma 9-Purinyl-Phosphonsäurederivate
DK0481214T3 (da) * 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
ES2139588T3 (es) * 1991-03-05 2000-02-16 Ajinomoto Kk Derivado de ciclopropano.
US5817647A (en) * 1993-04-01 1998-10-06 Merrell Pharmaceuticals Inc. Unsaturated acetylene phosphonate derivatives of purines
DE69426904T2 (de) * 1993-06-29 2001-10-11 Mitsubishi Chemical Corp., Tokio/Tokyo Phosphonat-Nukleotid Ester-Derivate
AU690587B2 (en) * 1993-09-17 1998-04-30 Gilead Sciences, Inc. Method for dosing therapeutic compounds
WO1995022330A1 (en) 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
IT1270008B (it) 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5874577A (en) * 1996-04-03 1999-02-23 Medichem Research, Inc. Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
US5877166A (en) * 1996-04-29 1999-03-02 Sri International Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US5935946A (en) * 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
CN1130362C (zh) 1997-08-15 2003-12-10 美迪维尔公司 核苷类似物,这些化合物作为包括乙型肝炎病毒(hbv)的逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
CA2479037C (en) * 2002-03-15 2010-11-09 Jiri Zemlicka 2-amino-9[(2-hydroxymethyl)cyclopropylidenemethyl]purines as antiviral agents
RU2005108601A (ru) * 2002-09-26 2006-01-20 Эл Джи Лайф Сайенсиз Лтд. (Kr) (+)-транс-изомеры(1-фосфонометокси-2-алкилциклопропил)метилнуклеозидные производные, способ получения их стереоизомеров и применение указанных соединений в качестве противовирусных средств

Also Published As

Publication number Publication date
ATE478887T1 (de) 2010-09-15
BR0206165A (pt) 2004-02-03
CA2433591A1 (en) 2002-07-25
KR20020062216A (ko) 2002-07-25
EP1358198A4 (en) 2008-03-05
PT1358198E (pt) 2010-10-01
WO2002057288A1 (en) 2002-07-25
EP1358198B1 (en) 2010-08-25
US20060293284A1 (en) 2006-12-28
ZA200304181B (en) 2004-10-06
US20100004440A1 (en) 2010-01-07
JP2004518675A (ja) 2004-06-24
US7605147B2 (en) 2009-10-20
PL212730B1 (pl) 2012-11-30
US7723319B2 (en) 2010-05-25
KR100441638B1 (ko) 2004-07-23
RU2003125372A (ru) 2005-01-20
DK1358198T3 (da) 2010-10-04
DE60237429D1 (de) 2010-10-07
US7157448B2 (en) 2007-01-02
EP1358198A1 (en) 2003-11-05
HK1062017A1 (en) 2004-10-15
JP3959348B2 (ja) 2007-08-15
NZ526632A (en) 2005-10-28
ES2350197T3 (es) 2011-01-20
CA2433591C (en) 2009-07-28
CN1487949A (zh) 2004-04-07
CN100347185C (zh) 2007-11-07
EG24382A (en) 2009-04-05
PL373670A1 (en) 2005-09-05
AU2002230230B2 (en) 2005-05-26
AR035933A1 (es) 2004-07-28
MY141789A (en) 2010-06-30
US20040063668A1 (en) 2004-04-01
RU2266294C2 (ru) 2005-12-20

Similar Documents

Publication Publication Date Title
MXPA03006001A (es) Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos.
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
DK1416935T3 (da) 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
IL158697A0 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
NO20020687D0 (no) 3(5)-ureidopyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
CA2378148A1 (en) Nematicidal trifluorobutenes
MXPA03010020A (es) PROCEDIMIETO PARA LA PREPARACIoN DE UREA.
HUP0202414A3 (en) Process for the preparation of perindopril, their analogous and their salts
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
MXPA03006606A (es) Proceso para preparacion de analogos de indeno heterociclico.
EP1176150A4 (en) A METHOD FOR PRODUCING TRIFLUOROTHYMIDINE DERIVATIVES
MXPA03001551A (es) Proceso continuo para preparacion de clorotiazoles pesticidas.
HUP0401617A3 (en) Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
MXPA03007624A (es) Procedimiento para la preparacion de (e)-5-(2-bromovinil)-2-desoxiuridina.
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
EP1186612A4 (en) PROCESS FOR THE PREPARATION OF CYTIDIN DERIVATIVES
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
HUP0402020A3 (en) A process for preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate

Legal Events

Date Code Title Description
FG Grant or registration